{"transactions":[{"id":864982,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-03T21:35:09.000Z","date":"2026-02-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":16375,"price":3.84,"value":62880.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 is being filed as an amendment to the Form 4 originally filed on February 20, 2026, to correct the number of shares reported as acquired upon the vesting and settlement of a performance share award and the number of shares reported as withheld in satisfaction of tax obligations in connection with such award. No other changes have been made to the original filing."}],"balance_after":1128312,"source":{"system":"sec-edgar","filing":"0002064832-26-000089","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000089/form4a.xml","form_type":"4/A","original_submission_date":"2026-02-20"}},{"id":864981,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-03T21:35:09.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":49102,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 is being filed as an amendment to the Form 4 originally filed on February 20, 2026, to correct the number of shares reported as acquired upon the vesting and settlement of a performance share award and the number of shares reported as withheld in satisfaction of tax obligations in connection with such award. No other changes have been made to the original filing."}],"balance_after":1144687,"source":{"system":"sec-edgar","filing":"0002064832-26-000089","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000089/form4a.xml","form_type":"4/A","original_submission_date":"2026-02-20"}},{"id":890186,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-20T22:28:06.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":120267,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option becomes exercisable in equal annual installments over four years beginning February 15, 2026."}],"balance_after":120267,"derivative":{"exercise_price":3.84,"expiration_date":"2036-02-18","underlying":"Class A Common Stock","underlying_shares":120267},"source":{"system":"sec-edgar","filing":"0002064832-26-000058","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000058/form4.xml","form_type":"4"}},{"id":890185,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-20T22:28:06.000Z","date":"2026-02-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":16212,"price":3.84,"value":62254.08,"ownership":{"direct":true},"balance_after":1127985,"source":{"system":"sec-edgar","filing":"0002064832-26-000058","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000058/form4.xml","form_type":"4"}},{"id":890184,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-20T22:28:06.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":48612,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares issued pursuant to the vesting and settlement of a performance share award granted in 2025 based on the achievement of certain performance milestones."}],"balance_after":1144197,"source":{"system":"sec-edgar","filing":"0002064832-26-000058","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000058/form4.xml","form_type":"4"}},{"id":890183,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-20T22:28:06.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":210937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") under the Organogenesis Holdings Inc. (\"Organogenesis\") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years beginning February 15, 2026."}],"balance_after":1095585,"source":{"system":"sec-edgar","filing":"0002064832-26-000058","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000058/form4.xml","form_type":"4"}},{"id":895675,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-18T21:37:32.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":15352,"price":3.73,"value":57262.96,"ownership":{"direct":true},"balance_after":884648,"source":{"system":"sec-edgar","filing":"0002064832-26-000030","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000030/form4.xml","form_type":"4"}},{"id":895674,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-18T21:37:32.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":15617,"price":3.73,"value":58251.41,"ownership":{"direct":true},"balance_after":900000,"source":{"system":"sec-edgar","filing":"0002064832-26-000030","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000030/form4.xml","form_type":"4"}},{"id":895673,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-18T21:37:32.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":28331,"price":3.73,"value":105674.63,"ownership":{"direct":true},"balance_after":915617,"source":{"system":"sec-edgar","filing":"0002064832-26-000030","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000030/form4.xml","form_type":"4"}},{"id":895672,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-18T21:37:32.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":5114,"price":3.73,"value":19075.22,"ownership":{"direct":true},"balance_after":943948,"source":{"system":"sec-edgar","filing":"0002064832-26-000030","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000206483226000030/form4.xml","form_type":"4"}},{"id":1252218,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-21T22:54:26.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":true,"shares":190475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable in equal annual installments over four years beginning February 15, 2025."}],"balance_after":190475,"derivative":{"exercise_price":3.53,"expiration_date":"2035-02-19","underlying":"Class A Common Stock","underlying_shares":190475},"source":{"system":"sec-edgar","filing":"0001062993-25-003233","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000106299325003233/form4.xml","form_type":"4"}},{"id":1252217,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2025-02-21T22:54:26.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":true,"shares":184136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") under the Organogenesis Holdings Inc. (\"Organogenesis\") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years beginning February 15, 2025."}],"balance_after":949062,"source":{"system":"sec-edgar","filing":"0001062993-25-003233","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000106299325003233/form4.xml","form_type":"4"}},{"id":1258552,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2025-02-20T00:18:40.000Z","date":"2025-02-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":790,"price":3.7,"value":2923.0,"ownership":{"direct":true},"balance_after":764926,"source":{"system":"sec-edgar","filing":"0001062993-25-002934","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000106299325002934/form4.xml","form_type":"4"}},{"id":1258551,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2025-02-20T00:18:40.000Z","date":"2025-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":3883,"price":3.7,"value":14367.1,"ownership":{"direct":true},"balance_after":765716,"source":{"system":"sec-edgar","filing":"0001062993-25-002934","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000106299325002934/form4.xml","form_type":"4"}},{"id":1258550,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2025-02-20T00:18:40.000Z","date":"2025-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":25739,"price":3.7,"value":95234.3,"ownership":{"direct":true},"balance_after":769599,"source":{"system":"sec-edgar","filing":"0001062993-25-002934","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000106299325002934/form4.xml","form_type":"4"}},{"id":1258549,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2025-02-20T00:18:40.000Z","date":"2025-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":13744,"price":3.7,"value":50852.8,"ownership":{"direct":true},"balance_after":795338,"source":{"system":"sec-edgar","filing":"0001062993-25-002934","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000106299325002934/form4.xml","form_type":"4"}},{"id":1548550,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2024-04-03T20:23:54.000Z","date":"2024-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":2497,"price":2.8,"value":6991.6,"ownership":{"direct":true},"balance_after":809082,"source":{"system":"sec-edgar","filing":"0001062993-24-007937","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000106299324007937/form4.xml","form_type":"4"}},{"id":1557400,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-29T20:19:57.000Z","date":"2024-03-28","kind":"exercise","planned":false,"acquired":false,"shares":152250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to this option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.18,"expiration_date":"2024-04-10","underlying":"Class A Common Stock","underlying_shares":152250},"source":{"system":"sec-edgar","filing":"0001062993-24-007462","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000106299324007462/form4.xml","form_type":"4"}},{"id":1557399,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2024-03-29T20:19:57.000Z","date":"2024-03-28","kind":"exercise","planned":false,"acquired":true,"shares":152250,"price":1.18,"value":179655.0,"ownership":{"direct":true},"balance_after":811579,"source":{"system":"sec-edgar","filing":"0001062993-24-007462","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000106299324007462/form4.xml","form_type":"4"}},{"id":1621697,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-23T22:23:12.000Z","date":"2024-02-21","kind":"grant","planned":false,"acquired":true,"shares":338674,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable in equal annual installments over four years beginning February 15, 2024."}],"balance_after":338674,"derivative":{"exercise_price":3.43,"expiration_date":"2034-02-21","underlying":"Class A Common Stock","underlying_shares":338674},"source":{"system":"sec-edgar","filing":"0001062993-24-004311","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000106299324004311/form4.xml","form_type":"4"}},{"id":1621696,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2024-02-23T22:23:12.000Z","date":"2024-02-21","kind":"grant","planned":false,"acquired":true,"shares":187318,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") under the Organogenesis Holdings Inc. (\"Organogenesis\") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years beginning February 15, 2024."}],"balance_after":659329,"source":{"system":"sec-edgar","filing":"0001062993-24-004311","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000106299324004311/form4.xml","form_type":"4"}},{"id":1632564,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2024-02-21T01:17:50.000Z","date":"2024-02-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":791,"price":3.48,"value":2752.68,"ownership":{"direct":true},"balance_after":472011,"source":{"system":"sec-edgar","filing":"0001062993-24-003760","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000106299324003760/form4.xml","form_type":"4"}},{"id":1632563,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2024-02-21T01:17:50.000Z","date":"2024-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":4608,"price":3.68,"value":16957.44,"ownership":{"direct":true},"balance_after":472802,"source":{"system":"sec-edgar","filing":"0001062993-24-003760","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000106299324003760/form4.xml","form_type":"4"}},{"id":1632562,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2024-02-21T01:17:50.000Z","date":"2024-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":24925,"price":3.68,"value":91724.0,"ownership":{"direct":true},"balance_after":477410,"source":{"system":"sec-edgar","filing":"0001062993-24-003760","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000106299324003760/form4.xml","form_type":"4"}},{"id":1926679,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2023-04-04T20:19:19.000Z","date":"2023-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":2678,"price":2.13,"value":5704.14,"ownership":{"direct":true},"balance_after":502335,"source":{"system":"sec-edgar","filing":"0001062993-23-008505","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000106299323008505/form4.xml","form_type":"4"}},{"id":1992281,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-24T22:50:08.000Z","date":"2023-02-22","kind":"grant","acquired":true,"shares":388654,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable in equal annual installments over four years beginning February 15, 2023."}],"balance_after":388654,"derivative":{"exercise_price":2.51,"expiration_date":"2033-02-22","underlying":"Class A Common Stock","underlying_shares":388654},"source":{"system":"sec-edgar","filing":"0001062993-23-004889","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000106299323004889/form4.xml","form_type":"4"}},{"id":1992280,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2023-02-24T22:50:08.000Z","date":"2023-02-22","kind":"grant","acquired":true,"shares":327386,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") under the Organogenesis Holdings Inc. (\"Organogenesis\") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years beginning February 15, 2023."}],"balance_after":505013,"source":{"system":"sec-edgar","filing":"0001062993-23-004889","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000106299323004889/form4.xml","form_type":"4"}},{"id":2006396,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2023-02-17T21:24:18.000Z","date":"2023-02-16","kind":"tax_withholding","acquired":false,"shares":936,"price":2.75,"value":2574.0,"ownership":{"direct":true},"balance_after":177627,"source":{"system":"sec-edgar","filing":"0001062993-23-004056","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000106299323004056/form4.xml","form_type":"4"}},{"id":2006395,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2023-02-17T21:24:18.000Z","date":"2023-02-15","kind":"tax_withholding","acquired":false,"shares":4599,"price":2.92,"value":13429.08,"ownership":{"direct":true},"balance_after":178563,"source":{"system":"sec-edgar","filing":"0001062993-23-004056","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000106299323004056/form4.xml","form_type":"4"}},{"id":2303404,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2022-04-05T22:17:48.000Z","date":"2022-04-01","kind":"tax_withholding","acquired":false,"shares":2497,"price":7.89,"value":19701.33,"ownership":{"direct":true},"balance_after":183162,"source":{"system":"sec-edgar","filing":"0001062993-22-009807","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000106299322009807/form4.xml","form_type":"4"}},{"id":2387360,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-17T23:55:15.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":125522,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable in equal annual installments over four years beginning February 15, 2022."}],"balance_after":125522,"derivative":{"exercise_price":8.03,"expiration_date":"2032-02-15","underlying":"Class A Common Stock","underlying_shares":125522},"source":{"system":"sec-edgar","filing":"0001062993-22-004800","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000106299322004800/form4.xml","form_type":"4"}},{"id":2387359,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2022-02-17T23:55:15.000Z","date":"2022-02-16","kind":"tax_withholding","acquired":false,"shares":937,"price":7.78,"value":7289.86,"ownership":{"direct":true},"balance_after":185659,"source":{"system":"sec-edgar","filing":"0001062993-22-004800","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000106299322004800/form4.xml","form_type":"4"}},{"id":2387358,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2022-02-17T23:55:15.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":52926,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") under the Organogenesis Holdings Inc. (\"Organogenesis\") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years beginning February 15, 2022."}],"balance_after":186596,"source":{"system":"sec-edgar","filing":"0001062993-22-004800","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000106299322004800/form4.xml","form_type":"4"}},{"id":2514235,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-12T23:01:45.000Z","date":"2021-11-10","kind":"exercise","acquired":false,"shares":30450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to this option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.44,"expiration_date":"2021-12-06","underlying":"Class A Common Stock","underlying_shares":30450},"source":{"system":"sec-edgar","filing":"0001661181-21-000068","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000166118121000068/edgar.xml","form_type":"4"}},{"id":2514234,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2021-11-12T23:01:45.000Z","date":"2021-11-10","kind":"exercise","acquired":true,"shares":30450,"price":1.44,"value":43848.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reporting person transferred 60,900 shares of Class A Common Stock held by the reporting person to his former spouse pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by his former spouse."}],"balance_after":133670,"source":{"system":"sec-edgar","filing":"0001661181-21-000068","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000166118121000068/edgar.xml","form_type":"4"}},{"id":2756651,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2021-04-06T00:47:20.000Z","date":"2021-04-01","kind":"tax_withholding","acquired":false,"shares":2497,"price":19.83,"value":49515.51,"ownership":{"direct":true},"balance_after":164120,"source":{"system":"sec-edgar","filing":"0000899243-21-014960","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000089924321014960/doc4.xml","form_type":"4"}},{"id":2848749,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-19T01:38:58.000Z","date":"2021-02-16","kind":"grant","acquired":true,"shares":82556,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable in equal annual installments over four years beginning February 16, 2021."}],"balance_after":82556,"derivative":{"exercise_price":13.68,"expiration_date":"2031-02-16","underlying":"Class A Common Stock","underlying_shares":82556},"source":{"system":"sec-edgar","filing":"0001661181-21-000027","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000166118121000027/edgar.xml","form_type":"4"}},{"id":2848748,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2021-02-19T01:38:58.000Z","date":"2021-02-16","kind":"grant","acquired":true,"shares":10782,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") under the Organogenesis Holdings Inc. (\"Organogenesis\") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years beginning February 16, 2021."}],"balance_after":166617,"source":{"system":"sec-edgar","filing":"0001661181-21-000027","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000166118121000027/edgar.xml","form_type":"4"}},{"id":3169918,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-24T11:47:49.000Z","date":"2020-04-22","kind":"grant","acquired":true,"shares":224185,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable in equal annual installments over four years beginning April 1, 2020."}],"balance_after":224185,"derivative":{"exercise_price":4.04,"expiration_date":"2030-04-22","underlying":"Class A Common Stock","underlying_shares":224185},"source":{"system":"sec-edgar","filing":"0001661181-20-000014","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000166118120000014/edgar.xml","form_type":"4"}},{"id":3169917,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2020-04-24T11:47:49.000Z","date":"2020-04-22","kind":"grant","acquired":true,"shares":34035,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") under the Organogenesis Holdings Inc. (\"Organogenesis\") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years beginning April 1, 2020."}],"balance_after":155835,"source":{"system":"sec-edgar","filing":"0001661181-20-000014","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000166118120000014/edgar.xml","form_type":"4"}},{"id":3733607,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-13T00:46:11.000Z","date":"2018-12-10","kind":"grant","acquired":true,"shares":101500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Received in connection with the Merger in exchange for an option to acquire 50,000 shares of common stock of Organogenesis for $7.01 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The shares underlying the option vested or shall vest 20% annually beginning on January 1, 2018."}],"balance_after":101500,"derivative":{"exercise_price":3.46,"expiration_date":"2027-05-04","underlying":"Common Stock","underlying_shares":101500},"source":{"system":"sec-edgar","filing":"0001661181-18-000035","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000166118118000035/edgar.xml","form_type":"4"}},{"id":3733606,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-13T00:46:11.000Z","date":"2018-12-10","kind":"grant","acquired":true,"shares":142100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Received in connection with the Merger in exchange for an option to acquire 70,000 shares of common stock of Organogenesis for $7.01 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares underlying the option vested or shall vest 20% annually beginning on December 31, 2017."}],"balance_after":142100,"derivative":{"exercise_price":3.46,"expiration_date":"2027-05-04","underlying":"Common Stock","underlying_shares":142100},"source":{"system":"sec-edgar","filing":"0001661181-18-000035","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000166118118000035/edgar.xml","form_type":"4"}},{"id":3733605,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-13T00:46:11.000Z","date":"2018-12-10","kind":"grant","acquired":true,"shares":152250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Received in connection with the Merger in exchange for an option to acquire 75,000 shares of common stock of Organogenesis for $2.38 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying the option vested or shall vest 20% annually beginning on January 1, 2015."}],"balance_after":152250,"derivative":{"exercise_price":1.18,"expiration_date":"2024-04-10","underlying":"Common Stock","underlying_shares":152250},"source":{"system":"sec-edgar","filing":"0001661181-18-000035","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000166118118000035/edgar.xml","form_type":"4"}},{"id":3733604,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-13T00:46:11.000Z","date":"2018-12-10","kind":"grant","acquired":true,"shares":30450,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received in connection with the Merger in exchange for an option to acquire 15,000 shares of common stock of Organogenesis for $2.92 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to this option are fully vested and exercisable."}],"balance_after":30450,"derivative":{"exercise_price":1.44,"expiration_date":"2021-12-06","underlying":"Common  Stock","underlying_shares":30450},"source":{"system":"sec-edgar","filing":"0001661181-18-000035","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000166118118000035/edgar.xml","form_type":"4"}},{"id":3733603,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63132,"kind":"person","name":"Bilbo Patrick","position":1,"cik":"0001759203","reported_name":"Bilbo Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-12-13T00:46:11.000Z","date":"2018-12-10","kind":"grant","acquired":true,"shares":121800,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in connection with the Issuer's business combination (the \"Merger\") with Organogenesis Inc. (\"Organogenesis\") in accordance with the terms of the Agreement and Plan of Merger dated as of August 17, 2018 among the Issuer, which was then referred to as Avista Healthcare Public Acquisition Corp., Avista Healthcare Merger Sub, Inc. and Organogenesis, in exchange for 60,000 shares of common stock of Organogenesis."}],"balance_after":121800,"source":{"system":"sec-edgar","filing":"0001661181-18-000035","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000166118118000035/edgar.xml","form_type":"4"}}]}